Trials / Unknown
UnknownNCT02108886
Pilot Study Testing a New Strategy for Management of Spontaneous Preterm Birth
Pilot Study Testing a New Strategy for Management of Spontaneous Preterm Birth.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Preterm birth is a major public health problem, and actual treatments are not very efficient. The purpose of this study is to test the efficiency of a combined use of Montelukast and Nifedipine to treat preterm labor. Investigators aim to reduce uterine contractions more efficiently than with the use of Nifedipine only.
Detailed description
An inflammatory process is involved in 60% of preterm births. Moreover, investigators previously demonstrated that enzymes of lipoxygenase pathway are present in uterine smooth muscle, and that an additive tocolytic effect can be obtained from the combined use of Montelukast and Nifedipine. Methods: This is a double-blinded randomized controlled assay performed at the CHUS on two groups of 50 women. Women will be selected when admitted for preterm labor with a gestational age between 26 and 34 weeks. The first group will receive Nifedipine for 48 hours, as described by the standard protocol at the CHUS, in addition to 10 mg of Montelukast per day, until delivery or 35 weeks of pregnancy. The second group will receive Nifedipine for 48 hours, as described by the standard protocol at the CHUS, in addition to a placebo per day, until delivery or 35 weeks of pregnancy. Cervical secretions and urine will be sample at the admission, after one week and every two weeks during treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Montelukast | 10 mg of Montelukast per day, from admission for preterm labor until delivery or 35 weeks of pregnancy. |
| DRUG | Placebo | empty capsule filled with sugar |
| OTHER | urine and vaginal secretions sampling | Urine and vaginal secretions sampling, once a week in both groups |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-07-01
- Completion
- 2015-12-01
- First posted
- 2014-04-09
- Last updated
- 2015-03-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02108886. Inclusion in this directory is not an endorsement.